Ranibizumab Intraocular and Vimovo

• Generic Name: ranibizumab ophthalmic
• Dosage Forms: n.a.
• Other Brand Names: Lucentis

Ranibizumab is used to treat neovascular (wet) age-related macular degeneration (AMD). AMD is a disorder of the retina in the eye that causes blurring of vision or blindness. Ranibizumab works by changing the amount of blood that gets to the eye.

Ranibizumab is also used to treat myopic choroidal neovascularization (mCNV).

Ranibizumab is used to treat macular edema (swelling of the back of the eye) after retinal vein occlusion (a blood vessel in the eye is blocked). It is also used in diabetic patients who have diabetic macular edema (DME). Macular edema can cause loss of vision. Ranibizumab is also used to treat diabetic retinopathy (eye problem caused by diabetes).

Ranibizumab is to be given only by or under the direct supervision of your doctor.

• Generic Name: esomeprazole / naproxen
• Dosage Forms: tablet, delayed release
• Other Brand Names: Vimovo

Vimovo contains a combination of esomeprazole and naproxen. Naproxen is a nonsteroidal anti-inflammatory drug (NSAID). It works by reducing substances in the body that cause inflammation, pain, and fever.

Esomeprazole is a proton pump inhibitor. It is included in Vimovo to decrease the amount of acid produced in the stomach.

Vimovo is used to treat symptoms of osteoarthritis, rheumatoid arthritis, juvenile idiopathic arthritis, and ankylosing spondylitis. The esomeprazole in this medicine helps reduce the risk of stomach ulcers in people who may be at risk for them while receiving treatment with an NSAID.